New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Editas Medicine, Inc. (EDIT) vs Lexeo Therapeutics, Inc. (LXEO)
- Editas Medicine, Inc. EDIT 1.64 −4.09%
- Lexeo Therapeutics, Inc. LXEO 2.96 +0.34%
Editas Medicine, Inc. and Lexeo Therapeutics, Inc. are both Biotechnology companies. Editas Medicine, Inc. and Lexeo Therapeutics, Inc. are of similar size ($267.4M and $263.9M). Across the 10 metrics below, Editas Medicine, Inc. leads on 5 and Lexeo Therapeutics, Inc. on 5.
Valuation
Profitability
| Metric | EDIT | LXEO | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | — | 70.18% |
| Operating margin | (151.71%) | — | 0.00% |
| Net margin | (144.95%) | — | 0.00% |
| Free cash flow margin | (221.15%) | — | 0.00% |
| Return on equity | (147.44%) | (62.39%) | (51.58%) |
| Return on assets | (34.30%) | (54.30%) | (45.91%) |
| Return on invested capital | 0.00% | (324.39%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack